Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313019622> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4313019622 abstract "Microvascular dysfunction contributes to adverse clinical outcomes in patients with peripheral artery disease (PAD). Compromised angiogenesis is an important mechanism of limb ischemia that may be a treatment target but is challenging to assess in patients. Selected circulating microRNA (miRNAs) have been implicated in the pathogenesis of PAD. Thus, we sought to characterize angiogenesis potential and identify altered miRNA in patients with PAD. We collected adipose tissue from ischemic limbs of patients with PAD (n=15, age=64±11, 33% women, 66% T2DM, 61% current smoking) at the time of revascularization surgery. Control adipose tissue was procured patients without PAD undergoing joint replacement surgery (n=6, age=58±6, 50% women, 17% T2DM, 33% current smoking). Using matrigel sprouting assay, we observed a significantly lower angiogenesis response over 8 days in adipose tissue samples from PAD patients compared to controls (p=0.008). We performed miRNA profiling using NextSeq (Illumina Inc.) sequencer. miRNA NGS libraries were prepared using QIAseq miRNA Library Kit. Quality controlled NGS libraries were sequenced according to the manufacturer protocol. Our results demonstrated 40 upregulated and 11 downregulated miRNAs (FDR q<0.01, log2 fold change>2). Using bioinformatics approaches to prioritize differentially expressed miRNA predicted to impact pathways relevant to cardiovascular disease, we identified miR205-5p and miR182-5p as top candidate. There were higher levels of miR205-5p (4.8-fold, FDRq=1.5e-10) and miR182-5p (4.1-fold, FDRq=5.4e-16) in adipose tissue from PAD patients compared to controls. We confirmed the differentially expressed levels using qPCR in selected samples. Ingenuity pathway analysis indicates that miR205-5p inhibits VEGF-A, a key regulator of angiogenesis. We observed a trend toward an association of miR205-5p (r=-0.58, p=0.1) and miR182-5p (r=-0.67, p=0.06) and lower angiogenesis response. Taken together our findings demonstrate impaired microvascular angiogenesis response in patients with PAD along with upregulation of selected miRNA predicted to impair angiogenesis pathways. Further work is needed to confirm a functional role of miRNA in the impaired angiogenesis in patients with PAD." @default.
- W4313019622 created "2023-01-05" @default.
- W4313019622 creator A5014646191 @default.
- W4313019622 creator A5014914458 @default.
- W4313019622 creator A5020832252 @default.
- W4313019622 creator A5070992899 @default.
- W4313019622 date "2022-05-01" @default.
- W4313019622 modified "2023-09-26" @default.
- W4313019622 title "Abstract 540: Impaired Microvascular Angiogenesis And Altered Tissue MicroRNA In Patients With Peripheral Artery Disease" @default.
- W4313019622 doi "https://doi.org/10.1161/atvb.42.suppl_1.540" @default.
- W4313019622 hasPublicationYear "2022" @default.
- W4313019622 type Work @default.
- W4313019622 citedByCount "0" @default.
- W4313019622 crossrefType "journal-article" @default.
- W4313019622 hasAuthorship W4313019622A5014646191 @default.
- W4313019622 hasAuthorship W4313019622A5014914458 @default.
- W4313019622 hasAuthorship W4313019622A5020832252 @default.
- W4313019622 hasAuthorship W4313019622A5070992899 @default.
- W4313019622 hasConcept C104317684 @default.
- W4313019622 hasConcept C126322002 @default.
- W4313019622 hasConcept C127561419 @default.
- W4313019622 hasConcept C142724271 @default.
- W4313019622 hasConcept C145059251 @default.
- W4313019622 hasConcept C171089720 @default.
- W4313019622 hasConcept C2778271429 @default.
- W4313019622 hasConcept C2778608917 @default.
- W4313019622 hasConcept C2779018089 @default.
- W4313019622 hasConcept C2779134260 @default.
- W4313019622 hasConcept C2780394083 @default.
- W4313019622 hasConcept C2780942790 @default.
- W4313019622 hasConcept C54355233 @default.
- W4313019622 hasConcept C60644358 @default.
- W4313019622 hasConcept C71924100 @default.
- W4313019622 hasConcept C86803240 @default.
- W4313019622 hasConceptScore W4313019622C104317684 @default.
- W4313019622 hasConceptScore W4313019622C126322002 @default.
- W4313019622 hasConceptScore W4313019622C127561419 @default.
- W4313019622 hasConceptScore W4313019622C142724271 @default.
- W4313019622 hasConceptScore W4313019622C145059251 @default.
- W4313019622 hasConceptScore W4313019622C171089720 @default.
- W4313019622 hasConceptScore W4313019622C2778271429 @default.
- W4313019622 hasConceptScore W4313019622C2778608917 @default.
- W4313019622 hasConceptScore W4313019622C2779018089 @default.
- W4313019622 hasConceptScore W4313019622C2779134260 @default.
- W4313019622 hasConceptScore W4313019622C2780394083 @default.
- W4313019622 hasConceptScore W4313019622C2780942790 @default.
- W4313019622 hasConceptScore W4313019622C54355233 @default.
- W4313019622 hasConceptScore W4313019622C60644358 @default.
- W4313019622 hasConceptScore W4313019622C71924100 @default.
- W4313019622 hasConceptScore W4313019622C86803240 @default.
- W4313019622 hasIssue "Suppl_1" @default.
- W4313019622 hasLocation W43130196221 @default.
- W4313019622 hasOpenAccess W4313019622 @default.
- W4313019622 hasPrimaryLocation W43130196221 @default.
- W4313019622 hasRelatedWork W1142302715 @default.
- W4313019622 hasRelatedWork W1994227279 @default.
- W4313019622 hasRelatedWork W1996390519 @default.
- W4313019622 hasRelatedWork W2054007578 @default.
- W4313019622 hasRelatedWork W2058103173 @default.
- W4313019622 hasRelatedWork W2225274455 @default.
- W4313019622 hasRelatedWork W2793712582 @default.
- W4313019622 hasRelatedWork W2921209636 @default.
- W4313019622 hasRelatedWork W4293585554 @default.
- W4313019622 hasRelatedWork W2810892597 @default.
- W4313019622 hasVolume "42" @default.
- W4313019622 isParatext "false" @default.
- W4313019622 isRetracted "false" @default.
- W4313019622 workType "article" @default.